Page results
-
Jean Degala tells us how the right support, teamwork, effective communication, determination and dedication have helped her grow into the role.
-
News and information from UCLH, including the latest team updates, technology updates and alerts and information we think you would find helpful
-
Getting Ready for Transition to Secondary School (GReaT) event for parents of children with type 1 diabetes
-
We are now administering new COVID-19 treatments for patients at highest risk in the community. The service can prescribe oral antivirals to be taken at home, and give intravenous antibody treatments at the hospital.
-
The resources for clinicians and patients are to support easier conversations about Parkinson’s dementia.
-
The Com-Cov trial in which UCLH is a site looking at alternating vaccines has been expanded to include the Moderna and Novavax vaccines.
-
Information for new neuro-otology patients
-
A BBC film which looks at the work of scientists at UCL and clinicians at UCLH working together on groundbreaking ‘first in-human’ immunotherapy trials is being shown again on BBC2 tonight.
-
A groundbreaking e-learning course dedicated to improving care and understanding of Sickle Cell Disorder (SCD) has been officially launched, marking a significant milestone in the fight against health inequalities.
-
People with obesity whose weight and health improve following drug treatment are likely to need the treatment long term, according to a UCLH and UCL study.
File results
-
FOI/2022/0278 - Surgical tables in use at Trust
-
FOI/2022/0280 - Applications or tools to communicate digitally with patients
-
FOI/2022/0282 - Decontamination and infection control leads; risk assessment group meetings
-
FOI/2022/0283 - Enhanced disinfection methods to eliminate HAIs in theatres, clinical areas and wards
-
FOI/2022/0285 - Paediatric audiology
-
FOI/2022/0286 - Fat-shaming complaints
-
FOI/2022/0287 - Device related delays in delivery of medication/ enteral feeding
-
FOI/2022/0288 - Patient deaths awaiting discharge as inpatient
-
FOI/2022/0293 - Patients treated with Ponvory, Tysabri, Vumerity, Zeposia
-
FOI/2022/0294 - IT systems validation document management system